Cardior
Patrick Waindok has worked as a Scientist at Cardior Pharmaceuticals since 2022, and previously worked as a Wissenschaftler at Stiftung Tierärztliche Hochschule Hannover from 2019.
Patrick Waindok obtained their Doctor of Philosophy - PhD from the Stiftung Tierärztliche Hochschule Hannover in 2019, having studied in the PhD Program "Animal and Zoonotic Infections" from 2014 to 2019.
Cardior
1 followers
Cardior develops novel, noncoding (ncRNA) RNA therapeutics for patients with myocardial infarction / heart failure.